Text Size

Evaluation of Pancreatic Pseudocyst Drainage With a Metal Stent

This study is currently recruiting participants.
Verified March 2013 by University of Florida
Sponsor:
Information provided by (Responsible Party):
University of Florida
ClinicalTrials.gov Identifier:
NCT01239056
First received: November 5, 2010
Last updated: March 14, 2013
Last verified: March 2013
History of Changes
  Purpose

The purpose of this study is to study the evaluation of the effectiveness of endoscopic Pancreatic Pseudocyst drainage using a metal stent.


Condition Intervention
Pancreatic Pseudocysts
 Procedure: Endoscopy

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Prospective Evaluation of the Clinical Utility of Pseudocyst Drainage With Metal Stent

Resource links provided by NLM:

MedlinePlus related topics: Endoscopy
U.S. FDA Resources

Further study details as provided by University of Florida:

Primary Outcome Measures:
  • Resolution of Pancreatic Pseudocyst after placement of metal stent. [ Time Frame: Approximately 2-3 hours ] [ Designated as safety issue: No ]
    This is an observational study to determine the effectiveness of using metal stents to drain pancreatic pseudocysts.


Estimated Enrollment: 150
Study Start Date: August 2009
Estimated Study Completion Date: August 2014
Estimated Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Pancreatic Pseudocysts
All adult patients who have a clinical indication to undergo an endoscopic drainage of a pancreatic pseudocyst.
 Procedure: Endoscopy
Endoscopic drainage of a pancreatic pseudocyst using a metal stent per medical indication.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients who have a medical indication for endoscopic drainage of pancreatic pseudocyst and are referred for the procedure as part of their standard medical care will be considered for the study.

Criteria

Inclusion Criteria:

  1. Subject is 18 years or older
  2. Subject has pancreatic pseudocyst
  3. Subject has medical indication for drainage of the pancreatic pseudocyst
  4. Subject must be able to give informed consent

Exclusion Criteria:

  1. Any contraindication to endoscopic pseudocyst drainage
  2. Subject is unable to give informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01239056

Contacts
Contact: Peter V Draganov, MD 352-273-9400 peter.draganov@medicine.ufl.edu

Locations
United States, Florida
Shands UF Endoscopy Recruiting
Gainesville, Florida, United States, 32608
Contact: Peter V Draganov, MD     352-273-9400     peter.draganov@medicine.ufl.edu    
Principal Investigator: Peter V Draganov, MD            
Sub-Investigator: Chris Forsmark, MD            
Sub-Investigator: Mihir Wagh, MD            
Sub-Investigator: Shailendra Chauhan, MD            
Sponsors and Collaborators
University of Florida
Investigators
Principal Investigator: Peter V draganov, MD University of Florida
  More Information

No publications provided

Responsible Party: University of Florida
ClinicalTrials.gov Identifier: NCT01239056     History of Changes
Other Study ID Numbers: Pancreatic Pseudocyst
Study First Received: November 5, 2010
Last Updated: March 14, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Pancreatic Pseudocyst
Pancreatic Cyst
Cysts
 Neoplasms
Pancreatic Diseases
Digestive System Diseases

ClinicalTrials.gov processed this record on May 21, 2013